Position in AZN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,330,162
-$180,259 QoQ
Shares Held
22,836
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#412
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sound View Wealth Advisors Group, LLC holds $97,551,908 across 10 Drug Manufacturers - General names. AZN ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,347 | $26,803,664 | |
| 2 | JNJ |
Johnson & Johnson
|
61,910 | $15,723,282 | |
| 3 | ABBV |
AbbVie Inc.
|
58,534 | $14,729,495 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
233,338 | $13,444,935 | |
| 5 | AMGN |
Amgen Inc
|
27,043 | $9,792,811 | |
| 6 | MRK |
Merck & Co., Inc.
|
62,066 | $7,975,481 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
22,836 | $4,330,162 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
26,642 | $3,365,950 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,330,162 | 22,836 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,510,421 | 22,870 | Shares | Sole | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||